{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:44:46Z","timestamp":1790009086345,"version":"4.0.1"},"reference-count":42,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T00:00:00Z","timestamp":1670457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>Recurrent Pregnancy Loss (RPL) affects between 1% to 5% of women of reproductive age. It is widely believed that RPL is a complex disorder that is influenced by chromosomal abnormalities, genetic mutations, uterine anatomic deformity, endocrine dysfunction, immunologic factors, infections, and the environment. Thrombotic disorders are a frequent cause of RPL, accounting for almost half of all cases; however, in the rest of the cases, the cause of RPL remains unclear. Therefore, in this study, it was planned to determine the genetic mutations involved in RPL during the first and second trimester of pregnancy. An observational retrospective cohort study was conducted in 2021, collecting data from 157 first trimester miscarriages and 54 s trimester pregnancies. All patients with a panel of laboratory and genetic analysis for thrombophilia were included for data analysis. It was observed that four factors were significantly more prevalent in one of the groups. Factor V Leiden (FVL) homozygosity and antiphospholipid syndrome (APS) antibodies were statistically significantly more common in pregnant women who suffered first trimester pregnancy losses. On the other hand, Protein C deficiency and Glycoprotein Ia polymorphism were statistically significantly more frequent in the second trimester group. The strongest independent risk factors for first trimester pregnancy loss were FVL and prothrombin (PT) compound mutations (OR = 3.11), followed by FVL homozygous mutation (OR = 3.66), and APS antibodies (OR = 4.47). Regarding second trimester pregnancy loss risk factors, the strongest were FVL and PT compound (OR = 3.24), followed by Glycoprotein Ia polymorphism (OR = 3.61), and respectively, APS antibodies (OR = 3.85). Numerous thrombophilic risk factors for early and late pregnancy loss have been found, including several mutations that seem to occur more often either during the first or the second trimester. Even though we are aware of risk-free and efficient diagnostics for thrombophilia abnormalities, no intervention has been proved to be clearly successful after the detection of these variables.<\/jats:p>","DOI":"10.3390\/ijerph192416500","type":"journal-article","created":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T02:20:31Z","timestamp":1670552431000},"page":"16500","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["A Retrospective Assessment of Thrombophilia in Pregnant Women with First and Second Trimester Pregnancy Loss"],"prefix":"10.3390","volume":"19","author":[{"given":"Olivera","family":"Iordache","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana Maria","family":"Anastasiu-Popov","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doru Mihai","family":"Anastasiu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius","family":"Craina","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Dahma","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geanina","family":"Sacarin","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Silaghi","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3730-6527","authenticated-orcid":false,"given":"Cosmin","family":"Citu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razvan","family":"Daniluc","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denisa","family":"Hinoveanu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogdan","family":"Feciche","sequence":"additional","affiliation":[{"name":"Department of Urology, Satu-Mare County Emergency Hospital, Strada Ravensburg 2, 440192 Satu-Mare, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4711-4315","authenticated-orcid":false,"given":"Felix","family":"Bratosin","sequence":"additional","affiliation":[{"name":"Methodological and Infectious Diseases Research Center, Department of Infectious Diseases, \u201cVictor Babes\u201d University of Medicine and Pharmacy, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4114-1582","authenticated-orcid":false,"given":"Radu","family":"Neamtu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,12,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"ESHRE Guideline Group on RPL, Bender Atik, R., Christiansen, O.B., Elson, J., Kolte, A.M., Lewis, S., Middeldorp, S., Nelen, W., Peramo, B., and Quenby, S. (2018). ESHRE guideline: Recurrent pregnancy loss. Hum. Reprod. Open, 2018, hoy004.","DOI":"10.1093\/hropen\/hoy004"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Practice Committee of the American Society for Reproductive Medicine (2012). Evaluation and treatment of recurrent pregnancy loss: A committee opinion. Fertil. Steril., 98, 1103\u20131111.","DOI":"10.1016\/j.fertnstert.2012.06.048"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e13551","DOI":"10.1111\/aji.13551","article-title":"Human forkhead box protein 3 gene variants associated with altered susceptibility to idiopathic recurrent pregnancy loss: A retrospective case-control study","volume":"88","author":"Bahia","year":"2022","journal-title":"Am. J. Reprod. Immunol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e13173","DOI":"10.1111\/aji.13173","article-title":"Maternal HLA-DR, -DQ, and -DP loci are linked with altered risk of recurrent pregnancy loss in Lebanese women: A case-control study","volume":"82","author":"Aimagambetova","year":"2019","journal-title":"Am. J. Reprod. Immunol."},{"key":"ref_5","first-page":"232840","article-title":"Acquired activated protein C resistance, thrombophilia and adverse pregnancy outcomes: A study performed in an Irish cohort of pregnant women","volume":"2011","author":"Lyons","year":"2011","journal-title":"J. Pregnancy"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Csutak, A., Steiber, Z., T\u0151zs\u00e9r, J., Jakab, A., Berta, A., and Silver, D.M. (2017). Plasminogen activator activity in tears of pregnant women. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0177003"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5830\/CVJA-2016-021","article-title":"Physiological changes in pregnancy","volume":"27","author":"Tolppanen","year":"2016","journal-title":"Cardiovasc. J. Afr."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"4359424","DOI":"10.1155\/2017\/4359424","article-title":"Adverse Pregnancy Outcomes of Patients with History of First-Trimester Recurrent Spontaneous Abortion","volume":"2017","author":"Yang","year":"2017","journal-title":"Biomed. Res. Int."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e691S","DOI":"10.1378\/chest.11-2300","article-title":"VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Bates","year":"2012","journal-title":"CHEST"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"28418","DOI":"10.3390\/ijms161226104","article-title":"Thrombophilia and Pregnancy Complications","volume":"16","author":"Simcox","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"ref_11","first-page":"351","article-title":"Inherited thrombophilia in pregnant women with intrauterine growth restriction","volume":"9","author":"Coriu","year":"2014","journal-title":"Maedica"},{"key":"ref_12","first-page":"76","article-title":"Inherited genetic markers for thrombophilia in northeastern Iran (a clinical-based report)","volume":"2","author":"Keify","year":"2014","journal-title":"Rep. Biochem. Mol. Biol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"516420","DOI":"10.1155\/2013\/516420","article-title":"The role of thrombophilia in pregnancy","volume":"2013","author":"Battinelli","year":"2013","journal-title":"Thrombosis"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Bernardes, T.P., Mol, B.W., Ravelli, A.C.J., van den Berg, P., Boezen, H.M., and Groen, H. (2020). Early and late onset pre-eclampsia and small for gestational age risk in subsequent pregnancies. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0230483"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1002\/art.40136","article-title":"Emerging Treatment Models in Rheumatology: Antiphospholipid Syndrome and Pregnancy: Pathogenesis to Translation","volume":"69","author":"Abrahams","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1055\/s-0044-100919","article-title":"Maternal Thrombophilia and Recurrent Miscarriage\u2014Is There Evidence That Heparin is Indicated as Prophylaxis against Recurrence?","volume":"78","author":"Stefanski","year":"2018","journal-title":"Geburtshilfe Frauenheilkd."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"852777","DOI":"10.3389\/fcvm.2022.852777","article-title":"Risk of Thrombosis, Pregnancy Morbidity or Death in Antiphospholipid Syndrome","volume":"9","author":"Killian","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1182\/blood-2016-03-703728","article-title":"Hereditary risk factors for thrombophilia and probability of venous thromboembolism during pregnancy and the puerperium","volume":"128","author":"Gerhardt","year":"2016","journal-title":"Blood"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s13317-011-0017-9","article-title":"Pathophysiology of the antiphospholipid antibody syndrome","volume":"2","author":"Willis","year":"2011","journal-title":"Autoimmun. Highlights"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/bjh.13209","article-title":"LMWH to prevent placenta-mediated pregnancy complications: An update","volume":"168","author":"Duffett","year":"2015","journal-title":"Br. J. Haematol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s10815-013-0071-5","article-title":"The association between thrombophilic gene mutations and recurrent pregnancy loss","volume":"30","author":"Chaparzadeh","year":"2013","journal-title":"J. Assist. Reprod. Genet."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/nur.20389","article-title":"The impact of miscarriage and parity on patterns of maternal distress in pregnancy","volume":"33","author":"Lobel","year":"2010","journal-title":"Res. Nurs. Health"},{"key":"ref_23","first-page":"76","article-title":"Recurrent pregnancy loss: Etiology, diagnosis, and therapy","volume":"2","author":"Ford","year":"2009","journal-title":"Rev. Obstet. Gynecol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"6057","DOI":"10.1016\/j.vaccine.2016.03.044","article-title":"Brighton Collaboration Stillbirth Working Group. Stillbirth: Case definition and guidelines for data collection, analysis, and presentation of maternal immunization safety data","volume":"34","author":"Gonik","year":"2016","journal-title":"Vaccine"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/S0140-6736(21)00682-6","article-title":"Miscarriage matters: The epidemiological, physical, psychological, and economic costs of early pregnancy loss","volume":"397","author":"Quenby","year":"2021","journal-title":"Lancet"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Cohain, J.S., Buxbaum, R.E., and Mankuta, D. (2017). Spontaneous first trimester miscarriage rates per woman among parous women with 1 or more pregnancies of 24 weeks or more. BMC Pregnancy Childbirth, 17.","DOI":"10.1186\/s12884-017-1620-1"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"810","DOI":"10.4103\/2230-8210.192903","article-title":"Trimester-specific reference interval for thyroid hormones during pregnancy at a Tertiary Care Hospital in Haryana, India","volume":"20","author":"Rajput","year":"2016","journal-title":"Indian J. Endocrinol. Metab."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1136\/bmj.329.7458.152","article-title":"Threatened miscarriage: Evaluation and management","volume":"329","author":"Sotiriadis","year":"2004","journal-title":"BMJ"},{"key":"ref_29","unstructured":"(1908). Inevitable Abortion and Its Treatment. Hospital, 44, 473."},{"key":"ref_30","unstructured":"Alves, C., and Rapp, A. (2022). Spontaneous Abortion. StatPearls, StatPearls Publishing."},{"key":"ref_31","first-page":"151","article-title":"Missed abortion and application of misoprostol","volume":"64","author":"Zeqiri","year":"2010","journal-title":"Med. Arh."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Rajbanshi, S., Norhayati, M.N., and Nik Hazlina, N.H. (2020). High-risk pregnancies and their association with severe maternal morbidity in Nepal: A prospective cohort study. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0244072"},{"key":"ref_33","first-page":"433","article-title":"Management of inherited thrombophilia in pregnancy","volume":"12","author":"Ormesher","year":"2016","journal-title":"Womens Health"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2141.2005.05847.x","article-title":"Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study, Thrombophilia in pregnancy: A systematic review","volume":"132","author":"Robertson","year":"2006","journal-title":"Br. J. Haematol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1056\/NEJM200002103420602","article-title":"Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium","volume":"342","author":"Gerhardt","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1001\/archinternmed.2008.589","article-title":"The value of family history as a risk indicator for venous thrombosis","volume":"169","author":"Bezemer","year":"2009","journal-title":"Arch. Intern. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"224","DOI":"10.4103\/0974-1208.170407","article-title":"Prevalence and role of antithrombin III, protein C and protein S deficiencies and activated protein C resistance in Kosovo women with recurrent pregnancy loss during the first trimester of pregnancy","volume":"8","author":"Mekaj","year":"2015","journal-title":"J. Hum. Reprod. Sci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e059519","DOI":"10.1136\/bmjopen-2021-059519","article-title":"Thrombophilia screening in women with recurrent first trimester miscarriage: Is it time to stop testing?\u2014A cohort study and systematic review of the literature","volume":"12","author":"Shehata","year":"2022","journal-title":"BMJ Open"},{"key":"ref_39","unstructured":"(2022, May 20). ESHRE Guideline \u2018Recurrent Pregnancy Loss\u2019 ESHRE Early Pregnancy Guideline Development Group Version 2.0. November 2017. Available online: https:\/\/www.eshre.eu\/Guidelines-and-Legal\/Guidelines\/Recurrent-pregnancy-loss."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/bmj.38498.669595.8F","article-title":"Selective chromosome analysis in couples with two or more miscarriages: Case-control study","volume":"331","author":"Franssen","year":"2005","journal-title":"BMJ"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.fertnstert.2009.06.041","article-title":"Etiology of recurrent pregnancy loss in women over the age of 35 years","volume":"94","author":"Marquard","year":"2010","journal-title":"Fertil. Steril."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.fertnstert.2012.03.038","article-title":"Is chromosome testing of the second miscarriage cost saving? A decision analysis of selective versus universal recurrent pregnancy loss evaluation. Is chromosome testing of the second miscarriage cost saving? A decision analysis of selective versus universal recurrent pregnancy loss evaluation","volume":"98","author":"Bernardi","year":"2012","journal-title":"Fertil. Steril."}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/19\/24\/16500\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:36:41Z","timestamp":1760146601000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/19\/24\/16500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,8]]},"references-count":42,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["ijerph192416500"],"URL":"https:\/\/doi.org\/10.3390\/ijerph192416500","relation":{},"ISSN":["1660-4601"],"issn-type":[{"value":"1660-4601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,8]]}}}